4-butyrolactone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, JG; Hsu, SC; Huang, YP; Kuo, YH; Lin, ML; Yu, CC; Yu, FS | 1 |
1 other study(ies) available for 4-butyrolactone and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
Topics: 4-Butyrolactone; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Squamous Cell Carcinoma of Head and Neck | 2016 |